High expression of a plectasin-derived peptide NZ2114 in Pichia pastoris and its pharmacodynamics, postantibiotic and synergy against Staphylococcus aureus

Applied Microbiology and Biotechnology

Volumn 98, Issue 2, 2014, Pages 681-694

  Zhang, Yong ^a,b   Teng, Da ^a,b   Mao, Ruoyu ^a,b   Wang, Xiumin ^a,b   Xi, Di ^a,b   Hu, Xiaoyuan ^a,b   Wang, Jianhua ^a,b  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

MRSA; NZ2114; PAE; Pichia pastoris; Synergy

Indexed keywords

ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, ION EXCHANGE; DRUG SYNERGISM; GENE EXPRESSION; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; PEPTIDES; PICHIA; RECOMBINANT PROTEINS; STAPHYLOCOCCUS AUREUS;

EID: 84895070137     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-013-4881-2     Document Type: Article

References (65)

1. Andes D, Craig W, Nielsen LA, Kristensen HH (2009) In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model. Antimicrob Agents Chemother 53:3003-3009
2. Archer GL, Scott J (1991) Conjugative transfer genes in Staphylococcal isolates from the United States. Antimicrob Agents Chemother 35:2500-2504
3. Brinch KS, Tulkens PM, Van Bambeke F, Frimodt-Møller N, Høiby N, Kristensen HH (2010) Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin. J Antimicrob Chemother 65:1720-1724
4. Burrowes OJ, Diamond G, Lee TC (2005) Recombinant expression of Pleurocidin cdna using the Pichia pastoris expression system. J Biomed Biotechnol 2005:374-384 (Pubitemid 43129209)
5. Cabral KMS, Almeida MS, Valente AP, Almeida FCL, Kurtenbach E (2003) Production of the active antifungal Pisum sativum defensin 1 (Psd1) in Pichia pastoris: overcoming the inefficiency of the STE13 protease. Protein Expr Purif 31:115-122 (Pubitemid 37207649)
6. Cereghino JL, Cregg JM (2006) Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev 24:45-66
7. Chambers HF, Kennedy S (1990) Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. Antimicrob Agents Chemother 34:510-514 (Pubitemid 20122273)
8. Cho J, Lee DG (2011) The characteristic region of arenicin-1 involved with a bacterial membrane targeting mechanism. Biochem Biophys Res Commun 405:422-427
9. Damasceno LM, Huang CJ, Batt CA (2012) Protein secretion in Pichia pastoris and advances in protein production. Appl Microbiol Biotechnol 1-9
10. Deresinski S (2009) Vancomycin in combination with other antibiotics for the treatment of serious methicillin resistant Staphylococcus aureus infections. Clin Infect Dis 49:1072-1079
11. Diekema D, Pfaller M, Schmitz F, Smayevsky J, Bell J, Jones R, Beach M (2001) Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the sentry antimicrobial surveillance program, 1997-1999. Clin Infect Dis 32:S114-S132
12. Eckert R (2011) Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Future Microbiol 6:635-651
13. Feng X-j, Wang J-h, Shan A-s, Teng D, Yang Y-l, Yao Y, Yang G-p, Shao Y-c, Liu S, Zhang F (2006) Fusion expression of bovine lactoferricin in Escherichia coli. Protein Expr Purif 47:110-117
14. Giguère S, Lee EA, Guldbech KM, Berghaus LJ (2012) In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi. Vet Microbiol 160:207-213
15. Gottlieb C, Thomsen L, Ingmer H, Mygind P, Kristensen H-H, Gram L (2008) Antimicrobial peptides effectively kill a broad spectrum of Listeria monocytogenes and Staphylococcus aureus strains independently of origin, sub-type, or virulence factor expression. BMC Microbiol 8:205
16. Hara S, Mukae H, Sakamoto N, Ishimoto H, Amenomori M, Fujita H, Ishimatsu Y, Yanagihara K, Kohno S (2008) Plectasin has antibacterial activity and no affect on cell viability or IL-8 production. Biochem Biophys Res Commun 374:709-713
17. Higgins DR, Cregg JM (1998) Introduction to Pichia pastoris. Methods in molecular biology 103:1-16
18. Hong F, Meinander NQ, Jönsson LJ (2002) Fermentation strategies for improved heterologous expression of laccase in Pichia pastoris. Biotechnol Bioeng 79:438-449 (Pubitemid 34847321)
19. Hong IP, Lee SJ, Kim YS, Choi SG (2007) Recombinant expression of human cathelicidin (hCAP18/LL-37) in Pichia pastoris. Biotechnol Lett 29:73-78 (Pubitemid 44950160)
20. Idiris A, Tohda H, Kumagai H, Takegawa K (2010) Engineering of protein secretion in yeast: strategies and impact on protein production. Appl Microbiol Biotechnol 86:403-417
21. Jahic M, Wallberg F, Bollok M, Garcia P, Enfors SO (2003) Temperature limited fed-batch technique for control of proteolysis in Pichia pastoris bioreactor cultures. Microb Cell Fact 2:6 (Pubitemid 38751435)
22. Jevons MP (1961) "Celbenin"-resistant staphylococci. Br Med J 1:124-125
23. Ju H, Liang D, Guo G (2003) Comparison of four methods to prepare Pichia genomic DNA for PCR. Tianjin Medical Journal 31:270-272
24. Jung HJ, Park Y, Sung WS, Suh BK, Lee J, Hahm KS, Lee DG (2007) Fungicidal effect of pleurocidin by membrane-active mechanism and design of enantiomeric analogue for proteolytic resistance. BBA-Biomembranes 1768:1400-1405 (Pubitemid 46782704)
25. Kardas P (2002) Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemoth 49:897-903 (Pubitemid 34692883)
26. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771 (Pubitemid 47598444)
27. Li P, Anumanthan A, Gao X-G, Ilangovan K, Suzara VV, Düzgü neş N, Renugopalakrishnan V (2007) Expression of recombinant proteins in Pichia pastoris. Appl Microbiol Biotechnol 142:105-124 (Pubitemid 47557234)
28. Li Z (2001) Low-temperature increases the yield of biologically active herring antifreeze protein in Pichia pastoris. Protein Expr Purif 21:438-445 (Pubitemid 34179417)
29. Ma D, Wang R, Liao W, Han Z, Liu S (2009) Identification and characterization of a novel antibacterial peptide, avian β-defensin 2 from ducks. J Microbiol 47:610-618
30. MacLeod DL, Barker LM, Sutherland JL, Moss SC, Gurgel JL, Kenney TF, Burns JL, Baker WR (2009) Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis. J Antimicrob Chemother 64:829-836
31. Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM (2005) Heterologous protein production using the Pichia pastoris expression system. Yeast 22:249-270 (Pubitemid 40528349)
32. Mao R, Teng D, Wang X, Xi D, Zhang Y, Hu X, Yang Y, Wang J (2013) Design, expression, and characterization of a novel targeted plectasin against methicillin-resistant Staphylococcus aureus. Appl Microbiol Biotechnol. 97:3991-4002
33. Moon JY, Henzler-Wildman KA, Ramamoorthy A (2006) Expression and purification of a recombinant LL-37 from Escherichia coli. BBA-Biomembranes 1758:1351-1358 (Pubitemid 44436070)
34. Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Sönksen CP, Ludvigsen S, Raventós D, Buskov S, Christensen B, De Maria L, Taboureau O, Yaver D, Elvig-Jørgensen SG, Sørensen MV, Christensen BE, Kjærulff S, Frimodt-Moller N, Lehrer RI, Zasloff M, Kristensen H-H (2005) Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437:975-980 (Pubitemid 41486973)
35. Murasugi A, Asami Y, Mera-Kikuchi Y (2001) Production of recombinant human bile salt-stimulated lipase in Pichia pastoris. Protein Expr Purif 23:282-288 (Pubitemid 33037796)
36. Nguyen HM, Graber CJ (2009) Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer. J Antimicrob Chemother 65:24-36
37. Ostergaard C, Sandvang D, Frimodt-Moller N, Kristensen HH (2009) High cerebrospinal fluid (CSF) penetration and potent bactericidal activity in csf of NZ2114, a novel plectasin variant, during experimental pneumococcal meningitis. Antimicrob Agents Chemother 53:1581-1585
38. Otter JA, French GL (2010) Molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 10:227-239
39. Pankuch GA, Appelbaum PC (2008) Postantibiotic effect of tigecycline against 14 gram-positive organisms. Antimicrob Agents Chemother 53:782-784
40. Pankuch GA, Appelbaum PC (2009) Post-antibiotic effect of ceftaroline against gram-positive organisms. Antimicrob Agents Chemother 53:4537-4539
41. Pankuch GA, Jacobs MR, Appelbaum PC (2003) Postantibiotic effects of daptomycin against 14 Staphylococcal and Pneumococcal clinical isolates. Antimicrob Agents Chemother 47:3012-3014 (Pubitemid 37040290)
42. Park Y, Park SN, Park SC, Shin SO, Kim JY, Kang SJ, Kim MH, Jeong CY, Hahm KS (2006) Synergism of Leu-Lys rich antimicrobial peptides and chloramphenicol against bacterial cells. Biochim Biophys Acta-Proteins & Proteomics 1764:24-32 (Pubitemid 43362828)
43. Raventos D, Taboureau O, Mygind P, Nielsen J, Sonksen C, Kristensen HH (2005) Improving on nature's defenses: optimization & high throughput screening of antimicrobial peptides. Comb Chem High Throughput Screen 8:219-233 (Pubitemid 40488602)
44. Rodriguez Jimenez E, Sánchez K, Roca H, Delgado J (1997) Different methanol feeding strategies to recombinant Pichia pastoris cultures producing high level of dextranase. Biotechnol Tech 11:461-466 (Pubitemid 27288715)
45. Rountree PM, Freeman BM (1955) Infections caused by a particular phage type of Staphylococcus aureus. Med J Aust 42:157
46. Schägger H (2006) Tricine-SDS-PAGE. Nat Protoc 1:16-22
47. Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, Jansen A, Nielsen AK, Mygind PH, Raventós DS (2010) Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 328:1168
48. Schnorr KM, Hansen MT, Mygind PH, Segura DR, Kristensen HH (2003) Antimicrobial polypeptides from Pseudoplectania nigrella. International Patent Application.WO 2003/044049 - A1
49. Soren Kjærulff (2009) BioBusiness: antimicrobial peptides - plectasin, Sept 8, 2009 (http://www.novozymes.com/en/investor/events- presentations/Documents/5-CMD-BB-AMP-SNK-FINAL.pdf). Accessed 9 Oct 2012
50. Tian Z, Dong T, Yang Y, Teng D, Wang J (2009) Expression of antimicrobial peptide LH multimers in Escherichia coli C43 (DE3). Appl Microbiol Biotechnol 83:143-149
51. Torres MK, Draghi DC, Pillar CM, Brown PN, Alluru V, Sahm DF, Sandvang D, Kristensen H (2008) Activity of NZ2114 against Staphylococcal, Streptococcal isolates, including resistant phenotypes. Poster F1-3962
52. Trucksis M, Hooper DC, Wolfson JS (1991) Emerging resistance to fluoroquinolones in staphylococci: an alert. Ann Intern Med 114:424-426
53. Tsuji BT, Rybak MJ (2006) Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin. Diagn Microbiol Infect Dis 54:73-77 (Pubitemid 41815191)
54. Wang Y, Jiang Y, Gong T, Cui X, Li W, Feng Y, Wang B, Jiang Z, Li M (2010) High-level expression and novel antifungal activity of mouse beta defensin-1 mature peptide in Escherichia coli. Appl Biochem Biotechnol 160:213-221
55. Watanabe T, Ohashi K, Matsui K, Kubota T (1997) Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 39:471-476 (Pubitemid 27196944)
56. White RL, Burgess DS, Manduru M, Bosso JA (1996) Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother 40:1914-1918 (Pubitemid 26277815)
57. Whittaker MM, Whittaker JW (2000) Expression of recombinant galactose oxidase by Pichia pastoris. Protein Expr Purif 20:105-111
58. Xie Y, He Y, Gehring A, Hu Y, Li Q, Tu SI, Shi X (2011) Genotypes and toxin gene profiles of Staphylococcus aureus clinical isolates from China. PLoS One 6:e28276
59. Xiong YQ, Hady WA, Deslandes A, Rey A, Fraisse L, Kristensen HH, Yeaman MR, Bayer AS (2011) Efficacy of NZ2114, a novel plectasin-derived cationic antimicrobial peptide antibiotic, in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 55:5325-5330
60. Yamada O, Sakamoto K, Tominaga M, Nakayama T, Koseki T, Fujita A, Akita O (2005) Cloning and heterologous expression of the antibiotic peptide (ABP) genes from Rhizopus oligosporus NBRC 8631. Biosci Biotechnol Biochem 69:477-482 (Pubitemid 40589105)
61. Yang Y, Teng D, Zhang J, Tian Z, Wang S, Wang J (2011) Characterization of recombinant plectasin: solubility, antimicrobial activity and factors that affect its activity. Biotechnol Prog 46:1050-1055
62. Zhang J, Yang Y, Teng D, Tian Z, Wang S, Wang J (2011) Expression of plectasin in Pichia pastoris and its characterization as a new antimicrobial peptide against Staphyloccocus and Streptococcus. Protein Expr Purif 78:189-196
63. Zhang W, Inan M, Meagher MM (2000) Fermentation strategies for recombinant protein expression in the methylotrophic yeast Pichia pastoris. Biotechnol Bioeng 5:275-287
64. Zhang Y, Liu R, Wu X (2007) The proteolytic systems and heterologous proteins degradation in the methylotrophic yeast Pichia pastoris. Ann Microbiol 57:553-560 (Pubitemid 351196967)
65. Zorko M, Japelj B, Hafner-Bratkovic I, Jerala R (2009) Expression, purification and structural studies of a short antimicrobial peptide. Biochim Biophys Acta-Biomembranes 1788:314-323